pyruvic acid and plx4032

pyruvic acid has been researched along with plx4032 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Beloueche-Babari, M; Delgado-Goni, T; Leach, MO; Marais, R; Miniotis, MF; Parkes, HG; Wantuch, S; Workman, P1
Acciardo, S; Baurain, JF; Bouzin, C; Gallez, B; Gourgue, F; Jordan, BF; Joudiou, N; Lacomblez, E; Mignion, L; Schoonjans, C1

Other Studies

2 other study(ies) available for pyruvic acid and plx4032

ArticleYear
The BRAF Inhibitor Vemurafenib Activates Mitochondrial Metabolism and Inhibits Hyperpolarized Pyruvate-Lactate Exchange in BRAF-Mutant Human Melanoma Cells.
    Molecular cancer therapeutics, 2016, Volume: 15, Issue:12

    Topics: Antineoplastic Agents; Cell Line, Tumor; Energy Metabolism; Gene Expression Regulation, Enzymologic; Glucose; Humans; Indoles; Lactates; Melanoma; Metabolomics; Mitochondria; Models, Biological; Mutation; Proto-Oncogene Proteins B-raf; Pyruvate Carboxylase; Pyruvic Acid; Sulfonamides; Vemurafenib

2016
Metabolic imaging using hyperpolarized
    Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:2

    Topics: Animals; Biomarkers, Tumor; Carbon Isotopes; Cell Line, Tumor; Drug Resistance, Neoplasm; Electron Spin Resonance Spectroscopy; Female; Glycolysis; Humans; Melanoma; Mice, Nude; Oximetry; Oxygen Consumption; Proto-Oncogene Proteins B-raf; Pyruvic Acid; Transcription, Genetic; Vemurafenib; Xenograft Model Antitumor Assays

2020